Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

被引：0
作者：
Zhihuang Hu
Ying Cheng
Hongyu Zhang
Caicun Zhou
Baohui Han
Yiping Zhang
Cheng Huang
Jianhua Chang
Xiangqun Song
Jun Liang
Houjie Liang
Chunxue Bai
Shiying Yu
Jia Chen
Jie Wang
Hongming Pan
Denesh K. Chitkara
Darcy A. Hille
Li Zhang
机构：
[1] Sun Yat-sen University Cancer Center,Department of Medical Oncology
[2] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China
[3] Jilin Province Cancer Hospital,The first Department of Internal Medicine
[4] The Fifth Affiliated Hospital of Sun Yat-sen University,Department of Oncology
[5] Tongji University,Cancer Institute, Department of Oncology, Shanghai Pulmonary Hospital, Medical School
[6] Shanghai Jiaotong University,Department of Pulmonary Medicine, Shanghai Chest Hospital
[7] Zhejiang Cancer Hospital,Department of Chemotherapy
[8] The Teaching Hospital of Fujian Medical University,Department of Medical Oncology, Fujian Provincial Cancer Hospital
[9] Fudan University Shanghai Cancer Center,Department of Medical Oncology
[10] Guangxi Zhuang Autonomous Region Tumor Hospital,Department of Chemotherapy
[11] Qingdao University,Department of Medical Oncology, the Affiliated Hospital of Medical College
[12] Third Military Medical University,Department of Oncology, Southwest Hospital
[13] Fudan University,Department of Pulmonary Medicine, Zhongshan Hospital
[14] Huazhong University of Science and Technology,Cancer Center, Tongji Hospital, Tongji Medical College
[15] Jiangsu Cancer Hospital,Department of Medical Oncology
[16] Beijing Cancer Hospital,Department of Thoracic Medical Oncology
[17] Zhejiang University School of Medicine,Department of Medical Oncology, Sir Run Run Shaw Hospital
[18] Merck Sharp & Dohme Corp.,undefined
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Nausea; Emesis; Aprepitant; Emetogenic chemotherapy; Standard antiemetic treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：979 / 987
页数：8
相关论文
共 88 条
[1]  
Hesketh PJ(2008)Chemotherapy-induced nausea and vomiting N Engl J Med 358 2482-2494
[2]  
Cohen L(2007)Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings Support Care Cancer 15 497-503
[3]  
de Moor CA(1981)Emesis as a critical problem in chemotherapy N Engl J Med 305 948-949
[4]  
Eisenberg P(2012)Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life Support Care Cancer 20 3141-3148
[5]  
Laszlo J(2012)Management of highly emetogenic chemotherapy Curr Opin Oncol 24 371-375
[6]  
Lucas VS(2004)Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer 100 2261-2268
[7]  
Fernandez-Ortega P(2011)Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting Ann N Y Acad Sci 1222 40-48
[8]  
Caloto MT(2009)Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting Br J Anaesth 103 7-13
[9]  
Chirveches E(1999)Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group N Engl J Med 340 190-195
[10]  
Warr D(2001)Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone J Clin Oncol 19 1759-1767
123456789